[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.27.4″ custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text admin_label=”Text” _builder_version=”4.27.4″ text_font_size=”16px” text_line_height=”1.9em” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||||false|false” custom_margin_tablet=”|||-32px|false|false” custom_margin_phone=”|||-32px|false|false” custom_margin_last_edited=”on|phone” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n
Montreal, March 16th, 2023 \u2013 Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix\u2122, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada.<\/p>\n
24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men.<\/p>\n
\u201cHealth Canada has approved Illuccix\u2122, providing Canadian physicians with a new diagnostic tool\u201d states Andr\u00e9 Gagnon, president of Isologic. \u201cIlluccix\u2122 is available from Isologic, which supplies it to the entire Canadian territory to ensure that all patients have access to Illuccix\u2122\u201d.<\/p>\n
The product is available in a cold kit or as a single dose.<\/p>\n
Please follow the link for the entire release here<\/span><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Montreal, March 16th, 2023 \u2013 Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix\u2122, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men. \u201cHealth Canada has […]<\/p>\n","protected":false},"author":1,"featured_media":3022,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"Montr\u00e9al, 16 mars 2023 <\/strong>- Isologic Radiopharmaceutiques Novateurs<\/strong> est fi\u00e8re d'annoncer que l'agent d'imagerie du cancer de la prostate<\/strong> Illuccix\u00ae<\/strong>, trousse de pr\u00e9paration de gallium Ga 68 Gozetotide,<\/strong> aussi connu sous le nom de PSMA-11<\/strong>, est maintenant disponible au Canada.\n\n24 000 hommes sont diagnostiqu\u00e9s avec un cancer de la prostate chaque ann\u00e9e au Canada, ce qui en fait le premier cancer chez les hommes.\n\n\u00ab\u00a0Sant\u00e9 Canada a approuv\u00e9 Illuccix\u00ae<\/strong>, offrant ainsi aux m\u00e9decins canadiens un nouvel outil de diagnostic\u00a0\u00bb, d\u00e9clare Andr\u00e9 Gagnon, pr\u00e9sident d'Isologic. \"Illuccix\u00ae<\/strong> est disponible aupr\u00e8s d'Isologic, qui l'approvisionne sur l'ensemble du territoire canadien afin d'assurer l'acc\u00e8s de tous les patients \u00e0 Illuccix\u00ae\".\n\nLe produit est disponible en format de trousse froide ou sous forme de dose.\n\nLisez le communiqu\u00e9 en entier ici\n\nhttps:\/\/www.newswire.ca\/news-releases\/isologic-launches-illuccix-r-psma-pet-imaging-agent-to-detect-prostate-cancer-838868605.html<\/a>","_et_gb_content_width":"","footnotes":""},"categories":[16,14,26,13],"tags":[],"class_list":["post-3018","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dans-la-presse","category-in-the-press-2","category-isologic-news-3","category-nouvelles-isologic"],"_links":{"self":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts\/3018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/comments?post=3018"}],"version-history":[{"count":0,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts\/3018\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/media\/3022"}],"wp:attachment":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/media?parent=3018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/categories?post=3018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/tags?post=3018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}